RTI Biologics, Inc. (RTIX) Reports In-Line Q3 EPS; Cuts Outlook
Tweet Send to a Friend
RTI Biologics, Inc. (NASDAQ: RTIX) reported Q3 EPS of ($0.01), in-line with the analyst estimate of ($0.01). Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
